000 02419cam a2200349 a 4500
003 EG-GiCUC
005 20250223032259.0
008 190511s2018 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.11.19.Ph.D.2018.Ma.I
100 0 _aManar Khaled Mohammed
245 1 0 _aIn vitro activity of single and combined antibiotics against carbapenem resistant enterobacteriaceae clinical isolates in relation to their resistance genes /
_cManar Khaled Mohammed ; Supervised Mohammed Amr Alkholy , Aisha Mohammed Abouaitta , Mervat Mohammed Eldamarawy
246 1 5 _aالنشاط المختبرى للمضادات الحيوية المنفردة والمجمعة ضد العزلات الاكلينيكية لبكتريا الانتيروباكتريسى المقاومة للكربابينيم وعلاقتها بجينات المقاومة
260 _aCairo :
_bManar Khaled Mohammed ,
_c2018
300 _a155 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Microbiology and Immunology
520 _aThe prevalence of carbapenem-resistant Enterobacteriaceae (CRE) is on the rise worldwide, posing a major public health threat as well as a serious concern for infection control management. Programs and policies for the rational use of antibiotics are urgently needed to minimize more colonization with CRE with restriction of extended spectrum carbapenems use. The aim of our study was the in vitro evaluation of the effectiveness of different single and combined therapeutic options against CRE infections. The isolates were collected at Theodor Bilharz Research Institute. CRE were detected using disc diffusion test as a screening test and carbapenemase enzyme production was confirmed by Carba NP test. Hospital acquired infections were frequently high representing 80% of the CRE isolates
530 _aIssued also as CD
653 4 _aCarbapenem-resistant enterobacteriaceae (CRE)
653 4 _aOXA-48
653 4 _aResistance genes
700 0 _aAisha Mohammed Abouaitta ,
_eSupervisor
700 0 _aMervat Mohammed Eldamarawy ,
_eSupervisor
700 0 _aMohammed Amr Alkholy ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aNazla
_eRevisor
905 _aShimaa
_eCataloger
942 _2ddc
_cTH
999 _c71912
_d71912